Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
Center for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30303, USA.
Nat Microbiol. 2017 Jun 30;2:17101. doi: 10.1038/nmicrobiol.2017.101.
Human respiratory syncytial virus (hRSV) is a major cause of morbidity and mortality in the paediatric, elderly and immune-compromised populations. A gap in our understanding of hRSV disease pathology is the interplay between virally encoded immune antagonists and host components that limit hRSV replication. hRSV encodes for non-structural (NS) proteins that are important immune antagonists; however, the role of these proteins in viral pathogenesis is incompletely understood. Here, we report the crystal structure of hRSV NS1 protein, which suggests that NS1 is a structural paralogue of hRSV matrix (M) protein. Comparative analysis of the shared structural fold with M revealed regions unique to NS1. Studies on NS1 wild type or mutant alone or in recombinant RSVs demonstrate that structural regions unique to NS1 contribute to modulation of host responses, including inhibition of type I interferon responses, suppression of dendritic cell maturation and promotion of inflammatory responses. Transcriptional profiles of A549 cells infected with recombinant RSVs show significant differences in multiple host pathways, suggesting that NS1 may have a greater role in regulating host responses than previously appreciated. These results provide a framework to target NS1 for therapeutic development to limit hRSV-associated morbidity and mortality.
人类呼吸道合胞病毒(hRSV)是导致儿科、老年和免疫功能低下人群发病和死亡的主要原因。我们对 hRSV 疾病病理学的理解存在一个空白,即病毒编码的免疫拮抗剂与宿主成分之间的相互作用,这些成分限制了 hRSV 的复制。hRSV 编码非结构(NS)蛋白,这些蛋白是重要的免疫拮抗剂;然而,这些蛋白在病毒发病机制中的作用尚未完全了解。在这里,我们报告了 hRSV NS1 蛋白的晶体结构,该结构表明 NS1 是 hRSV 基质(M)蛋白的结构类似物。与 M 共享结构折叠的比较分析揭示了 NS1 所特有的区域。对 NS1 野生型或突变型的单独研究或在重组 RSV 中的研究表明,NS1 所特有的结构区域有助于调节宿主反应,包括抑制 I 型干扰素反应、抑制树突状细胞成熟和促进炎症反应。用重组 RSV 感染 A549 细胞的转录谱显示多个宿主途径存在显著差异,这表明 NS1 可能在调节宿主反应方面发挥的作用比以前认为的更大。这些结果为针对 NS1 的治疗性开发提供了一个框架,以限制与 hRSV 相关的发病率和死亡率。